(RNY.DE) Fundamental Analysis & Valuation

FRA:RNY • CA98462Y1007

Current stock price

5.391 EUR
-0.05 (-0.88%)
Last:

This RNY.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. RNY.DE Profitability Analysis

1.1 Basic Checks

  • In the past year RNY was profitable.
  • In the past year RNY had a positive cash flow from operations.
RNY.DE Yearly Net Income VS EBIT VS OCF VS FCFRNY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500M -500M

1.2 Ratios

  • The profitability ratios for RNY are negative, so there is not much use analyzing them.
  • The Return On Invested Capital of RNY (3.82%) is worse than 60.00% of its industry peers.
  • RNY had an Average Return On Invested Capital over the past 3 years of 4.60%. This is below the industry average of 9.17%.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 3.82%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.6%
ROIC(5y)N/A
RNY.DE Yearly ROA, ROE, ROICRNY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 -10 -20

1.3 Margins

  • Looking at the Operating Margin, with a value of 17.93%, RNY is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
  • RNY's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 56.94%, RNY belongs to the top of the industry, outperforming 92.50% of the companies in the same industry.
  • In the last couple of years the Gross Margin of RNY has grown nicely.
Industry RankSector Rank
OM 17.93%
PM (TTM) N/A
GM 56.94%
OM growth 3Y5.08%
OM growth 5Y11.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.44%
GM growth 5Y6.17%
RNY.DE Yearly Profit, Operating, Gross MarginsRNY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. RNY.DE Health Analysis

2.1 Basic Checks

  • RNY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, RNY has about the same amount of shares outstanding.
  • Compared to 1 year ago, RNY has a worse debt to assets ratio.
RNY.DE Yearly Shares OutstandingRNY.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M
RNY.DE Yearly Total Debt VS Total AssetsRNY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B 8B

2.2 Solvency

  • RNY has an Altman-Z score of 0.60. This is a bad value and indicates that RNY is not financially healthy and even has some risk of bankruptcy.
  • RNY's Altman-Z score of 0.60 is on the low side compared to the rest of the industry. RNY is outperformed by 70.00% of its industry peers.
  • The Debt to FCF ratio of RNY is 36.55, which is on the high side as it means it would take RNY, 36.55 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 36.55, RNY is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.25 indicates that RNY is not too dependend on debt financing.
  • RNY has a Debt to Equity ratio of 0.25. This is comparable to the rest of the industry: RNY outperforms 52.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 36.55
Altman-Z 0.6
ROIC/WACC0.37
WACC10.34%
RNY.DE Yearly LT Debt VS Equity VS FCFRNY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that RNY should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.44, RNY is doing worse than 72.50% of the companies in the same industry.
  • RNY has a Quick Ratio of 1.00. This is a normal value and indicates that RNY is financially healthy and should not expect problems in meeting its short term obligations.
  • RNY has a Quick ratio of 1.00. This is comparable to the rest of the industry: RNY outperforms 45.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1
RNY.DE Yearly Current Assets VS Current LiabilitesRNY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. RNY.DE Growth Analysis

3.1 Past

  • The earnings per share for RNY have decreased by -3.23% in the last year.
  • Measured over the past years, RNY shows a very strong growth in Earnings Per Share. The EPS has been growing by 37.97% on average per year.
  • RNY shows a decrease in Revenue. In the last year, the revenue decreased by -0.45%.
  • Measured over the past years, RNY shows a small growth in Revenue. The Revenue has been growing by 0.04% on average per year.
EPS 1Y (TTM)-3.23%
EPS 3Y44.23%
EPS 5Y37.97%
EPS Q2Q%-30%
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y3.88%
Revenue growth 5Y0.04%
Sales Q2Q%-9.23%

3.2 Future

  • The Earnings Per Share is expected to decrease by -44.78% on average over the next years. This is quite bad
  • Based on estimates for the next years, RNY will show a decrease in Revenue. The Revenue will decrease by -3.15% on average per year.
EPS Next Y-9.36%
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%
EPS Next 5YN/A
Revenue Next Year-0.27%
Revenue Next 2Y-0.71%
Revenue Next 3Y-3.15%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RNY.DE Yearly Revenue VS EstimatesRNY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RNY.DE Yearly EPS VS EstimatesRNY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

2

4. RNY.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.97, the valuation of RNY can be described as rather expensive.
  • RNY's Price/Earnings ratio is a bit more expensive when compared to the industry. RNY is more expensive than 60.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.87, RNY is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 21.64, which indicates a rather expensive current valuation of RNY.
  • The rest of the industry has a similar Price/Forward Earnings ratio as RNY.
  • RNY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 38.51.
Industry RankSector Rank
PE 19.97
Fwd PE 21.64
RNY.DE Price Earnings VS Forward Price EarningsRNY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as RNY.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of RNY is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 243
EV/EBITDA 7.73
RNY.DE Per share dataRNY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • RNY's earnings are expected to decrease with -44.78% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.53
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. RNY.DE Dividend Analysis

5.1 Amount

  • RNY has a Yearly Dividend Yield of 1.26%. Purely for dividend investing, there may be better candidates out there.
  • RNY's Dividend Yield is comparable with the industry average which is at 1.54.
  • Compared to the average S&P500 Dividend Yield of 1.81, RNY is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
RNY.DE Yearly Dividends per shareRNY.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 0.05 0.1 0.15

5.3 Sustainability

  • The earnings of RNY are negative and hence is the payout ratio. RNY will probably not be able to sustain this dividend level.
DP-11.67%
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%
RNY.DE Yearly Income VS Free CF VS DividendRNY.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 0 200M -200M -400M -600M -800M

More info and screens

Find the best dividend stocksShow peers with best dividend

RNY.DE Fundamentals: All Metrics, Ratios and Statistics

FRA:RNY (3/31/2023, 7:00:00 PM)

5.391

-0.05 (-0.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.19B
Revenue(TTM)1.81B
Net Income(TTM)-982.30M
Analysts73.33
Price Target5.98 (10.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP-11.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.14%
Min EPS beat(2)16.48%
Max EPS beat(2)21.8%
EPS beat(4)4
Avg EPS beat(4)24.88%
Min EPS beat(4)16.48%
Max EPS beat(4)36.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-2.82%
Max Revenue beat(2)-2.13%
Revenue beat(4)1
Avg Revenue beat(4)-1.46%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)3.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)30.1%
PT rev (3m)38.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.63%
EPS NY rev (1m)0%
EPS NY rev (3m)18.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.12%
Valuation
Industry RankSector Rank
PE 19.97
Fwd PE 21.64
P/S 3.13
P/FCF 243
P/OCF 10.72
P/B 1.73
P/tB 1.96
EV/EBITDA 7.73
EPS(TTM)0.27
EY5.01%
EPS(NY)0.25
Fwd EY4.62%
FCF(TTM)0.02
FCFY0.41%
OCF(TTM)0.5
OCFY9.33%
SpS1.72
BVpS3.12
TBVpS2.75
PEG (NY)N/A
PEG (5Y)0.53
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 3.82%
ROICexc 4.09%
ROICexgc 4.39%
OM 17.93%
PM (TTM) N/A
GM 56.94%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.6%
ROIC(5y)N/A
ROICexc(3y)4.33%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y15.46%
ROICexgc growth 5Y19.42%
ROICexc growth 3Y15.08%
ROICexc growth 5Y19.12%
OM growth 3Y5.08%
OM growth 5Y11.32%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.44%
GM growth 5Y6.17%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 36.55
Debt/EBITDA 1.08
Cap/Depr 108.14%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1
Altman-Z 0.6
F-Score3
WACC10.34%
ROIC/WACC0.37
Cap/Depr(3y)87.77%
Cap/Depr(5y)87.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.23%
EPS 3Y44.23%
EPS 5Y37.97%
EPS Q2Q%-30%
EPS Next Y-9.36%
EPS Next 2Y-5.84%
EPS Next 3Y-44.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.45%
Revenue growth 3Y3.88%
Revenue growth 5Y0.04%
Sales Q2Q%-9.23%
Revenue Next Year-0.27%
Revenue Next 2Y-0.71%
Revenue Next 3Y-3.15%
Revenue Next 5YN/A
EBIT growth 1Y-37.38%
EBIT growth 3Y9.16%
EBIT growth 5Y11.36%
EBIT Next Year131.94%
EBIT Next 3Y19.93%
EBIT Next 5YN/A
FCF growth 1Y-93.49%
FCF growth 3Y-50.33%
FCF growth 5YN/A
OCF growth 1Y-28.86%
OCF growth 3Y0.4%
OCF growth 5Y2.03%

/ RNY.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ?

ChartMill assigns a fundamental rating of 4 / 10 to RNY.DE.


What is the valuation status for RNY stock?

ChartMill assigns a valuation rating of 3 / 10 to (RNY.DE). This can be considered as Overvalued.


How profitable is (RNY.DE) stock?

(RNY.DE) has a profitability rating of 4 / 10.


What is the earnings growth outlook for ?

The Earnings per Share (EPS) of (RNY.DE) is expected to decline by -9.36% in the next year.


Can you provide the dividend sustainability for RNY stock?

The dividend rating of (RNY.DE) is 4 / 10 and the dividend payout ratio is -11.67%.